Literature DB >> 7643122

Opposing actions of thrombin and protease nexin-1 on amyloid beta-peptide toxicity and on accumulation of peroxides and calcium in hippocampal neurons.

V L Smith-Swintosky1, S Zimmer, J W Fenton, M P Mattson.   

Abstract

Amyloid beta-peptide (A beta) is the principal component of neuritic plaques in the brain in Alzheimer's disease (AD). Recent studies revealed that A beta can be neurotoxic by a mechanism involving free radical production and loss of cellular ion homeostasis, thus implicating A beta as a key factor in the pathogenesis of AD. However, other proteins are present in plaques in AD, including the protease thrombin and protease nexin-1 (PN1), a thrombin inhibitor. We therefore tested the hypothesis that thrombin and PN1 modify neuronal vulnerability to A beta toxicity. In dissociated rat hippocampal cell cultures the toxicity of A beta was significantly enhanced by coincubation with thrombin, whereas PN1 protected neurons against A beta toxicity. A beta induced an increase in levels of intracellular peroxides and calcium. Thrombin enhanced, and PN1 attenuated, the accumulation of peroxides and calcium induced by A beta. Taken together, these data demonstrate that thrombin and PN1 have opposing effects on neuronal vulnerability to A beta and suggest that thrombin and PN1 play roles in the pathogenesis of neuronal injury in AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643122     DOI: 10.1046/j.1471-4159.1995.65031415.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities.

Authors:  F M Donovan; C J Pike; C W Cotman; D D Cunningham
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

3.  Protease nexin I (PNI) in mouse brain is expressed from the same gene as in seminal vesicle.

Authors:  B A Citron; K T Ratzlaff; I V Smirnova; B W Festoff
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease.

Authors:  Xiangling Yin; Jill Wright; Trevor Wall; Paula Grammas
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

5.  Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.

Authors:  Daruoosh Zare; Mohammad Amin Rajizadeh; Marzieh Maneshian; Hossein Jonaidi; Vahid Sheibani; Majid Asadi-Shekaari; Manouchehr Yousefi; Khadijeh Esmaeilpour
Journal:  Psychopharmacology (Berl)       Date:  2021-02-23       Impact factor: 4.530

6.  Involvement of PGE2 and PGDH but not COX-2 in thrombin-induced cortical neuron apoptosis.

Authors:  Lakshmi Thirumangalakudi; Haripriya Vittal Rao; Paula Grammas
Journal:  Neurosci Lett       Date:  2009-01-21       Impact factor: 3.046

7.  Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.

Authors:  Lalida Rojanathammanee; Angela M Floden; Gunjan D Manocha; Colin K Combs
Journal:  J Neuroinflammation       Date:  2015-03-04       Impact factor: 8.322

Review 8.  Role of Thrombin in Central Nervous System Injury and Disease.

Authors:  Nathan A Shlobin; Meirav Har-Even; Ze'ev Itsekson-Hayosh; Sagi Harnof; Chaim G Pick
Journal:  Biomolecules       Date:  2021-04-12

9.  Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1.

Authors:  Bruce A Citron; Syed Ameenuddin; K Uchida; William Z Suo; Karen SantaCruz; Barry W Festoff
Journal:  Brain Res       Date:  2016-04-30       Impact factor: 3.610

Review 10.  The Importance of Thrombin in Cerebral Injury and Disease.

Authors:  Harald Krenzlin; Viola Lorenz; Sven Danckwardt; Oliver Kempski; Beat Alessandri
Journal:  Int J Mol Sci       Date:  2016-01-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.